Labcorp Holdings Inc. stock falls for fifth consecutive day

7 articles · Updated · MarketWatch · Apr 28

Shares closed at $259.57 on Tuesday, down 1.47%, with trading volume reaching 766,370—well above the 50-day average of 610,944.
Labcorp's stock is now 11.63% below its 52-week high of $293.72, last reached on October 21st, 2025.
Despite the losses, Labcorp outperformed some competitors during a broadly negative market session, as the S&P 500 and Dow Jones also declined.

Why is Labcorp's stock falling despite strong profits and a positive 2026 outlook?

Is Labcorp's 11% dip from its peak a major warning or a prime buying opportunity?

With competitors like Centene surging, what is the hidden pressure on Labcorp's stock?

Can Labcorp's groundbreaking Alzheimer's test reverse its five-day stock market losing streak?

How will new FDA rules and a tech talent war affect Labcorp's innovation pipeline?